Latest Breaking News On - Asami fukunaga - Page 1 : comparemela.com

In a study reported in the  Journal of Controlled Release, researchers from Okayama University describe the use of nanocarriers in selectively transporting anticancer drugs to brain tumors. Glioblastoma is an aggressive form of brain cancer that is best treated with boron neutron capture therapy (BNCT). BNCT involves the use of an agent that delivers boron into tumor tissues. When subsequently hit with radiation, boron (typically the 10B isotope is used) emits particles that kill neighboring cells. However, current methods do not cargo boron into cancer cells homogenously. Now, Associate professor MICHIUE Hiroyuki and Okayama university Neutron Therapy Research Center (NTRC) team have successfully used a nanocarrier that selectively delivers boron into brain tumors.

Kita kuShuichi furuyaMizuki kitamatsuKazuyo igawaAtsushi fujimuraAsami fukunagaNatsuko kondoNobushige tsuboiHideki matsuiHiroaki matsushitaHiroyuki michiueSustainable development goalsOkayama universityPublic relations divisionNeutron therapy research centerControlled release